---
title: Chapter 5 — Implementation, Evaluation and Project Outcomes
kind: living-project-document
status: living
last_verified: 2026-09-04
---

# Chapter 5 — Implementation, Evaluation and Project Outcomes

## What this chapter must demonstrate

Per the [official guide, Chapter 5](../guide/technical-document-guide-2026.md): provide evidence that the solution was implemented, tested, evaluated, improved, and prepared for operational use. This chapter replaces a vague "Findings" section with verifiable engineering results: requirements fulfillment reported via the traceability matrix, actual test evidence and defect outcomes, user acceptance evaluation, candid discussion of limitations, deployment/handover status, and evidence-based conclusions. Every reported value must come from real test runs, logs, or signed validation records — the evidence files below fill in as work completes; nothing is pre-filled. Do not copy guide text; do not import claims from obsolete manuscript drafts.

## 5.1 Implemented Solution and Key Technical Features

[To be drafted — see guide section 5.1](../guide/technical-document-guide-2026.md)

### Working notes (from repository evidence)

- Implemented architecture and modules: [AGENTS.md](../../../AGENTS.md), [docs/cloie-techstack.md](../../cloie-techstack.md), feature domains under [src/features/](../../../src/features/)
- Implemented user-facing capability per role: [docs/product/overview.md](../../product/overview.md), [docs/system-cloie-user-journeys.md](../../system-cloie-user-journeys.md)
- Screenshots only where they demonstrate important functionality (guide §5.1); the manuscript must not become a screen-by-screen user manual.

## 5.2 Requirements Fulfillment

[To be drafted — see guide section 5.2](../guide/technical-document-guide-2026.md)

### Working notes (from repository evidence)

- Report status via the RTM; do not restate: [docs/capstone/evidence/requirements-traceability.md](../evidence/requirements-traceability.md)
- Implemented, partially implemented, changed, or deferred items must be justified against the requirement change log in the same RTM.

## 5.3 Testing and Quality Evaluation Results

[To be drafted — see guide section 5.3](../guide/technical-document-guide-2026.md)

### Working notes (from repository evidence)

- Actual test evidence accumulates in: [docs/capstone/evidence/testing-validation.md](../evidence/testing-validation.md)
- Quality characteristics selection follows ISO/IEC 25010:2023 per guide §V; justify which characteristics matter rather than mechanically testing every one.
- Production browser evidence process (performance traces, no-session boundary checks): [docs/testing/production-browser-evidence.md](../../testing/production-browser-evidence.md)

## 5.4 Alpha/Beta/Pilot/User Acceptance Evaluation

[To be drafted — see guide section 5.4](../guide/technical-document-guide-2026.md)

### Working notes (from repository evidence)

- Participant details, instruments, results, and revisions are **pending** — no UAT has been recorded yet; see the pending placeholders in [docs/capstone/evidence/testing-validation.md](../evidence/testing-validation.md) (Appendix G-2/G-4 sections)
- Protect participant privacy; avoid exposing personal data; minimize identifiers (guide §5.4 and the evidence retention note in Appendix G).

## 5.5 Discussion of Results and Limitations

[To be drafted — see guide section 5.5](../guide/technical-document-guide-2026.md)

### Working notes (from repository evidence)

- Known deferred/unsuitable areas already recorded in domain docs must be disclosed, not hidden: e.g. the ILO-to-PLO crosswalk is explicitly deferred ([src/features/outcomes/CONTEXT.md](../../../src/features/outcomes/CONTEXT.md)); readiness snapshot legacy semantics ([src/features/outcomes/CONTEXT.md](../../../src/features/outcomes/CONTEXT.md)); outstanding operational backup readiness ([docs/operations/deployment-inventory.md](../../operations/deployment-inventory.md))
- Defects and technical debt discussion draws from the issue/revision log: [docs/capstone/evidence/testing-validation.md](../evidence/testing-validation.md) (Appendix G-3)

## 5.6 Deployment, Handover and Operational Readiness

[To be drafted — see guide section 5.6](../guide/technical-document-guide-2026.md)

### Working notes (from repository evidence)

- Deployment evidence skeleton and handover checklist: [docs/capstone/evidence/deployment-handover.md](../evidence/deployment-handover.md)
- Actual deployment state: [docs/operations/deployment-inventory.md](../../operations/deployment-inventory.md), [docs/architecture/deployment.md](../../architecture/deployment.md)
- Institutional turnover policy context: [docs/institutional/isdrt-policy.md](../../institutional/isdrt-policy.md)

## 5.7 Conclusions and Recommendations

[To be drafted — see guide section 5.7](../guide/technical-document-guide-2026.md)

### Working notes (from repository evidence)

- Conclusions must be evidence-based against the objectives and success criteria defined in Chapter 1 ([01-project-context-and-definition.md](01-project-context-and-definition.md)) and verified in the RTM ([docs/capstone/evidence/requirements-traceability.md](../evidence/requirements-traceability.md))
- Recommendations may draw on explicitly deferred work already documented in ADRs and CONTEXT.md files (e.g. ILO-to-PLO crosswalk, backup scheduling); do not invent future-scope commitments.
